Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
A Next-Generation BRAF Inhibitor Overcomes Resistance to BRAF Inhibition in Patients with BRAF-Mutant Cancers Using Pharmacokinetics-Informed Dose Escalation.
Journal: Cancer discovery
Published: January 18, 2024
Randomized, Double-Blind, Placebo-Controlled Phase III Study of Paclitaxel ± Napabucasin in Pretreated Advanced Gastric or Gastroesophageal Junction Adenocarcinoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: December 15, 2021
Targeted eHealth Intervention to Reduce Breast Cancer Survivors' Fear of Recurrence: Results From the FoRtitude Randomized Trial.
Journal: Journal of the National Cancer Institute
Published: November 25, 2020
Evaluating the efficacy of vaginal dehydroepiandosterone for vaginal symptoms in postmenopausal cancer survivors: NCCTG N10C1 (Alliance).
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: January 27, 2017
Long-term Peripheral Neuropathy in Breast Cancer Patients Treated With Adjuvant Chemotherapy: NRG Oncology/NSABP B-30.
Journal: Journal of the National Cancer Institute
Published: January 20, 2017
Extending Aromatase-Inhibitor Adjuvant Therapy to 10 Years.
Journal: The New England journal of medicine
Published: June 07, 2016
Anastrozole versus tamoxifen in postmenopausal women with ductal carcinoma in situ undergoing lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial.
Journal: Lancet (London, England)
Published: December 22, 2015
Patient-reported outcomes with anastrozole versus tamoxifen for postmenopausal patients with ductal carcinoma in situ treated with lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial.
Journal: Lancet (London, England)
Published: December 22, 2015
Phase II randomized clinical trial evaluating neoadjuvant chemotherapy regimens with weekly paclitaxel or eribulin followed by doxorubicin and cyclophosphamide in women with locally advanced HER2-negative breast cancer: NSABP Foundation Study FB-9.
Journal: Breast cancer research and treatment
Published: June 05, 2015
North Central Cancer Treatment Group N10C2 (Alliance): a double-blind placebo-controlled study of magnesium supplements to reduce menopausal hot flashes.
Journal: Menopause (New York, N.Y.)
Published: November 26, 2014
Showing 1-11 of 11
Last Updated: 09/26/2026